Basal cell carcinoma is the most common type of skin cancer and develops in basal cells within the outer layer of the skin. It often appears on sun exposed areas, including the face, neck, and ears. Recognizing changes in the skin can support early diagnosis and appropriate treatment. Understanding its symptoms, risk factors.
Basal cell carcinoma (BCC) is a type of skin cancer that usually grows slowly and rarely spreads to distant parts of the body. However, untreated tumors can grow into nearby tissues and damage the skin, cartilage, or bone. Long term exposure to ultraviolet radiation from sunlight or tanning equipment is a major risk factor. Although BCC can affect people with different skin tones, identifying unusual or persistent skin changes is important for timely medical evaluation.
Basal cell carcinoma can look different depending on its location, subtype, and stage of development. Some lesions resemble small bumps, while others appear as flat, scaly, or scar like patches. The condition may develop gradually, making it important to pay attention to skin changes that do not heal.
Common symptoms and risk factors include:
Pearly or shiny bumps: A small, translucent or pink bump may develop, sometimes with visible blood vessels.
Open sores: A lesion may bleed, develop a crust, heal temporarily, and then reopen.
Flat or scaly patches: Some BCCs appear as reddish or brownish areas that persist or slowly enlarge.
Scar like skin changes: Certain tumors create pale, firm areas that resemble scars without a clear history of injury.
Ultraviolet exposure: Frequent sun exposure, sunburns, and indoor tanning increase the risk of developing BCC.
Other risk factors: Older age, a history of skin cancer, weakened immune function, and certain inherited conditions can increase susceptibility.
A persistent, changing, bleeding, or nonhealing skin lesion should be examined by a qualified healthcare professional. Symptoms alone cannot confirm whether a lesion is cancerous.
Diagnosis generally begins with a skin examination. A dermatologist assesses the lesion's appearance, location, size, and growth pattern. A skin biopsy, in which a small tissue sample is removed for laboratory examination, is commonly used to confirm the diagnosis. Treatment selection depends on the tumor's characteristics, location, and risk of recurrence, along with the patient's overall health.
Common diagnostic and treatment approaches include:
Surgical excision: The doctor removes the tumor along with a margin of surrounding tissue to help ensure that cancer cells are removed.
Mohs surgery: This technique removes thin layers of tissue and examines them under a microscope until no cancer cells remain in the examined margins. It is often considered for tumors in sensitive areas or those with a higher risk of recurrence.
Topical medicines: Prescription creams, including imiquimod or 5-fluorouracil, may be used for selected superficial BCCs when clinically appropriate. They are not suitable for every tumor type.
Curettage and electrodesiccation: For selected low-risk lesions, a clinician scrapes away the tumor and uses an electrical instrument to destroy remaining cancerous tissue.
Radiation therapy: Radiation may be considered when surgery is unsuitable or in certain other clinical circumstances.
Advanced treatments: Targeted medicines or immunotherapy may be options for some locally advanced or metastatic cases when surgery or radiation cannot adequately treat the disease.
Regular follow up appointments help monitor the treated area and identify possible new skin cancers. Sun protection measures, such as wearing protective clothing, using broad spectrum sunscreen, and avoiding indoor tanning, can help reduce additional ultraviolet exposure. Treatment decisions should be made with a qualified healthcare professional based on the individual diagnosis and clinical needs.